The PE Ratio as of November 2024 (TTM) for IN8bio, Inc. (INAB) is -0.43

According to IN8bio, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -0.43. This represents a change of -62.55% compared to the average of -1.15 of the last 4 quarters.

IN8bio, Inc. (INAB) Historical PE Ratio (quarterly & annually)

How has INAB PE Ratio performed in the past?

The mean historical PE Ratio of IN8bio, Inc. over the last ten years is -16.46. The current -0.43 PE Ratio has changed 161.28% with respect to the historical average. Over the past ten years (40 quarters), INAB's PE Ratio was at its highest in in the September 2024 quarter at -0.45. The PE Ratio was at its lowest in in the March 2018 quarter at -29.66.

IN8bio, Inc. (INAB) PE Ratio by Quarter and Year

Discovering the peaks and valleys of IN8bio, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

IN8bio, Inc. (INAB) Average PE Ratio

How has INAB PE Ratio performed in the past?

The current PE Ratio of IN8bio, Inc. (INAB) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

IN8bio, Inc. (INAB) PE Ratio vs. Peers

How is INAB’s PE Ratio compared to its peers?

IN8bio, Inc.’s PE Ratio is greater than Reviva Pharmaceuticals Holdings, Inc. (-1.19), greater than Cue Biopharma, Inc. (-1.17), greater than Lantern Pharma Inc. (-1.74), greater than Gracell Biotechnologies Inc. (-29.05), greater than Anixa Biosciences, Inc. (-8.30), greater than INmune Bio, Inc. (-2.38), greater than PolyPid Ltd. (-0.84), greater than Zura Bio Limited (-5.60), greater than Annexon, Inc. (-6.12), greater than Icosavax, Inc. (-15.78), greater than Wave Life Sciences Ltd. (-13.27), greater than Gain Therapeutics, Inc. (-2.14), less than TFF Pharmaceuticals, Inc. (-0.08), greater than aTyr Pharma, Inc. (-2.33), less than Palisade Bio, Inc. (-0.26), less than ContraFect Corporation (-0.19), less than Allarity Therapeutics, Inc. (-0.10), less than CNS Pharmaceuticals, Inc. (-0.16), less than Windtree Therapeutics, Inc. (-0.03),

Build a custom stock screener for IN8bio, Inc. (INAB) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like IN8bio, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

IN8bio, Inc. (INAB) and other stocks custom spreadsheet templates

The easiest way to analyze a company like IN8bio, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.